Tobramycin Inhalation Solution (300 mg/5 mL) | Tobramycin [Holopack Verpackungstechnik GmbH] | BioPortfolio

13:42 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Tobramycin Inhalation solution, for oral inhalation use

1 carton = 504 ampoules

Tobramycin Inhalation Solution (300 mg/5 mL)

Lot: UP115

Exp: 12-2019

Caution: For manufacturing, processing, or repacking.

Store at 2°-8°C (36°-46°F). Do not freeze.

9 boxes of 14 pouches of 4 ampoules of 5 mL

Carton # 0180

Made in Germany

Dr. Reddy's Laboratories SA

Elisabethenanlage 11,CH

Basel, CH, Switzerland - 4051


Holopack Verpackungstechnik GmbH

Active Ingredients


Drugs and Medications [81 Associated Drugs and Medications listed on BioPortfolio]

Tobramycin [rpk pharmaceuticals, inc.]

Tobramycin Ophthalmic Solution USP, 0.3%

Tobramycin [proficient rx lp]

Tobramycin Ophthalmic Solution USP, 0.3% (Sterile)

Tobramycin [a-s medication solutions]

Tobramycin Ophthalmic Solution USP, 0.3%

Tobramycin [direct rx]


Tobramycin [rebel distributors corp]

TobramycinOphthalmic Solution USP, 0.3% (Sterile)

Clinical Trials [55 Associated Clinical Trials listed on BioPortfolio]

Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis

OBJECTIVES: I. Determine the safety and efficacy of tobramycin in patients with cystic fibrosis who are chronically colonized with Pseudomonas aeruginosa. II. Determine whether this tr...

Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery

This randomized controlled trial compares two regimens of topical therapy: - tobramycin 0.3% - dexamethasone 0.1% (TobraDex®, Alcon), one drop four times/day - combination of tobr...

Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

This study compares the safety of the tobramycin solution for inhalation with the tobramycin dry powder formulation, used with a simple inhaler

Loteprednol Etabonate and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

This study is to evaluate the safety and efficacy of loteprednol etabonate [LE] and tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in the treatm...

Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa

This is a phase 3 study. Patients will be enrolled from 14 medical centers in mainland China. Eligible patients will be randomly allocated to treatment group (tobramycin nebulization, 300m...

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Intermittent inhaled tobramycin and systemic cytokines response in CF patients with Pseudomonas aeruginosa.

CF pulmonary guidelines recommend alternate therapy (one month on, one month off) with inhaled tobramycin for chronic Pseudomonas aeruginosa colonization in cystic fibrosis (CF). Tobramycin-inhaled po...

In vivo efficacy of tobramycin-loaded synthetic calcium phosphate beads in a rabbit model of staphylococcal osteomyelitis.

Osteomyelitis is an acute or chronic inflammatory process of the bone following infection with pyogenic organisms like Staphylococcus aureus. Tobramycin (TOB) is a promising aminoglycoside antibiotic ...

Electrochemical detection of tobramycin based on enzymes-assisted dual signal amplification by using a novel truncated aptamer with high affinity.

An aptamer with the length of only 15 nucleotides specific for tobramycin was obtained through rationally designed truncation from a previously reported long sequence. The structural and binding prope...

The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.

To assess the ability of oxyclozanide to enhance tobramycin killing of Pseudomonas aeruginosa biofilms and elucidate its mechanism of action.

Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.

The potential of azithromycin to alter the antimicrobial and clinical benefits of inhaled tobramycin in CF patients has been previously reported. The potential interaction between azithromycin and int...

Quick Search


Drugs and Medication Quicklinks

Searches Linking to this Drug Record